General Information of the Compound
| Compound ID |
CP0233329
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
CEFACLOR
Show/Hide
|
||||||||||||||||||
| Synonyms |
(6R,7R)-7-((R)-2-Amino-2-phenylacetamido)-3-chloro-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid monohydrate
(6R,7R)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid hydrate
(6R,7R)-7-{[(2R)-2-amino-2-phenylacetyl]amino}-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
3-Chloro-7-D-(2-phenylglycinamido)-3-cephem-4-carboxylic acid
3-Chloro-7-D-(2-phenylglycinamido)-3-cephem-4-carboxylic acid monohydrate
7-(2-Amino-2-phenyl-acetylamino)-3-chloro-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid
7beta-{[(2R)-2-amino-2-phenylacetyl]amino}-3-chloro-3,4-didehydrocepham-4-carboxylic acid
Alenfral
Alenfral (TN)
Alfacet
Alfatil
Alfatil Kapseln
CCL
Ceclor
Ceclor (TN)
Ceclor, Distaclor, Keflor, Raniclor, Cefaclor
Cefaclor
Cefaclor (JP15)
Cefaclor (USP)
Cefaclor [USAN:INN:BAN:JAN]
Cefaclor anhydrous
Cefaclor hydrate
Cefaclor monohydrate
Cefaclor-1-wasser
Cefaclorum
Distaclor
Distaclor (TN)
Dystaclor MR
Keflor (TN)
Kefolor
Kefolor Suspension
L-Kefral
Lilly 99638 hydrate
Muco Panoral
Panacef
Panoral
Raniclor (TN)
S-6472
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C15H14ClN3O4S
|
||||||||||||||||||
| Molecular Weight |
367.814
|
||||||||||||||||||
| Canonical SMILES |
N[C@@H](C(=O)N[C@H]1[C@H]2SCC(Cl)=C(N2C1=O)C(O)=O)c1ccccc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C15H14ClN3O4S/c16-8-6-24-14-10(13(21)19(14)11(8)15(22)23)18-12(20)9(17)7-4-2-1-3-5-7/h1-5,9-10,14H,6,17H2,(H,18,20)(H,22,23)/t9-,10-,14-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
QYIYFLOTGYLRGG-GPCCPHFNSA-N
|
||||||||||||||||||
| CAS |
53994-73-3
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound